MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Cutera Total Assets 2011-2026 | CUTR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 346 M | 521 M | 280 M | 133 M | 114 M | 97.6 M | 111 M | 91.9 M | 77.5 M | 109 M | 109 M | 113 M | 111 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 521 M | 77.5 M | 170 M |
Quarterly Total Assets Cutera
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234 M | 276 M | 346 M | 407 M | 464 M | 500 M | 521 M | 428 M | 424 M | 267 M | 280 M | 268 M | 264 M | 260 M | 133 M | 133 M | 133 M | 133 M | 114 M | 114 M | 114 M | 114 M | 97.6 M | 97.6 M | 97.6 M | 97.6 M | 111 M | 111 M | 111 M | 111 M | 91.9 M | 91.9 M | 91.9 M | 91.9 M | 77.5 M | 77.5 M | 77.5 M | 77.5 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 113 M | 113 M | 113 M | 113 M | 111 M | 111 M | 111 M | 111 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 521 M | 77.5 M | 170 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 90.43 | 2.07 % | $ 12.2 B | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.11 | -2.88 % | $ 258 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.38 | -0.98 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.8 | -5.53 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 54.48 | 0.63 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.52 | -0.13 % | $ 2.97 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.77 | -2.04 % | $ 69 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.82 | -0.75 % | $ 371 M | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 86.33 | 0.06 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.42 | -1.16 % | $ 128 M |  France |
 |
Myomo
MYO
|
38.6 M | $ 0.67 | -4.85 % | $ 28 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 168.21 | -2.13 % | $ 12.6 B | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.81 | 0.34 % | $ 468 M |  Curacao |
 |
AxoGen
AXGN
|
222 M | $ 31.01 | -4.99 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Insulet Corporation
PODD
|
3.19 B | $ 204.23 | 0.36 % | $ 14.4 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.76 | 9.09 % | $ 7.65 M | USA |
 |
Smith & Nephew plc
SNN
|
10.5 B | $ 31.76 | -2.67 % | $ 23.8 B |  Britain |
 |
Butterfly Network
BFLY
|
256 M | $ 4.02 | -2.66 % | $ 851 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 331.18 | -0.34 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 24.16 | -1.67 % | $ 553 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.7 | 11.11 % | $ 32.9 M | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 107.91 | 2.97 % | $ 3.67 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 18.66 | -2.66 % | $ 1.27 B | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.68 | -0.21 % | $ 347 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.33 | -2.01 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.09 | 1.05 % | $ 1.66 B | USA |